Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nicole Vitullo currently holds 65,000 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicole Vitullo has been a net buyer of ESPR stock. They have purchased $101.8M and sold $12.6M worth of shares.
Nicole Vitullo's most recent insider trade was on May 23, 2024, when they sold 65,000 shares at $0.00 per share.
Nicole Vitullo serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 239 insider transactions totaling $114.4M over their tenure at the company.
Nicole Vitullo holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Nicole Vitullo has shown a buying trading pattern, with $101.8M in total purchases and $12.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Nicole Vitullo was on Jan 28, 2020, when they sold $21.4M worth of ACHN shares. This transaction involved 3,393,382 shares at $6.30 per share.
Nicole Vitullo currently owns 65,000 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nicole Vitullo's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nicole Vitullo has 239 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for Nicole Vitullo and 40,000+ other insiders.